athenahealth Inc. (NASDAQ:ATHN) was upgraded by equities research analysts at Evercore ISI from a “hold” rating to a “buy” rating in a note issued to investors on Monday.

Several other research analysts have also weighed in on the company. Stifel Nicolaus began coverage on athenahealth in a research report on Wednesday, August 31st. They issued a “hold” rating for the company. Zacks Investment Research raised athenahealth from a “sell” rating to a “hold” rating in a research report on Thursday, August 4th. Jefferies Group reissued an “underperform” rating and issued a $105.00 price objective on shares of athenahealth in a research report on Monday, July 25th. Morgan Stanley lowered their price objective on athenahealth from $186.00 to $153.00 and set an “overweight” rating for the company in a research report on Monday, July 25th. Finally, FBR & Co lowered their price objective on athenahealth from $145.00 to $140.00 and set a “market perform” rating for the company in a research report on Friday, July 22nd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and nine have issued a buy rating to the company. athenahealth presently has a consensus rating of “Hold” and an average price target of $149.58.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) opened at 125.97 on Monday. athenahealth has a 52-week low of $114.59 and a 52-week high of $170.42. The stock’s 50 day moving average price is $123.18 and its 200 day moving average price is $129.87. The firm has a market capitalization of $4.96 billion, a PE ratio of 463.12 and a beta of 1.28.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 21st. The company reported $0.34 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by $0.08. The company had revenue of $261.90 million for the quarter, compared to analyst estimates of $274.07 million. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. On average, analysts predict that athenahealth will post $1.77 EPS for the current fiscal year.

In related news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $128.19, for a total value of $512,760.00. Following the transaction, the chief executive officer now owns 312,109 shares in the company, valued at $40,009,252.71. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Karl Stubelis sold 928 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $123.36, for a total value of $114,478.08. Following the completion of the transaction, the vice president now owns 1,375 shares in the company, valued at approximately $169,620. The disclosure for this sale can be found here. 3.04% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of the stock. 1st Global Advisors Inc. increased its position in athenahealth by 1.5% in the second quarter. 1st Global Advisors Inc. now owns 1,633 shares of the company’s stock valued at $225,000 after buying an additional 24 shares during the last quarter. Metropolitan Life Insurance Co. NY increased its stake in athenahealth by 1.3% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,929 shares of the company’s stock valued at $404,000 after buying an additional 39 shares in the last quarter. FineMark National Bank & Trust increased its stake in athenahealth by 4.5% in the second quarter. FineMark National Bank & Trust now owns 944 shares of the company’s stock valued at $130,000 after buying an additional 41 shares in the last quarter. IBM Retirement Fund increased its stake in athenahealth by 1.3% in the second quarter. IBM Retirement Fund now owns 3,933 shares of the company’s stock valued at $543,000 after buying an additional 51 shares in the last quarter. Finally, Integrated Investment Consultants LLC increased its stake in athenahealth by 6.9% in the second quarter. Integrated Investment Consultants LLC now owns 1,481 shares of the company’s stock valued at $204,000 after buying an additional 96 shares in the last quarter.

About athenahealth

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

5 Day Chart for NASDAQ:ATHN

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.